Metraipolis › archive › dc_c0b5cc84fa2d
Efficacy and safety of a modified ozone-mediated neurolysis in treatment for patients with resistant hypertension — Europe PMC PMID:41238812
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41238812
- DOI
- 10.1038/s41440-[numero omesso]-8
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T14:01:40.418Z
- SHA-256 of the archived text
e82bf101b7e621b460d5d17da6355942a88b9fac4dc48b3178334ad24d267e49- Stable URL of this page
https://metraipolis.com/documento/dc_c0b5cc84fa2d
How to cite
Efficacy and safety of a modified ozone-mediated neurolysis in treatment for patients with resistant hypertension — Europe PMC PMID:41238812 — Europe PMC (en), https://europepmc.org/article/MED/41238812 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c0b5cc84fa2d (Metraipolis archive dc_c0b5cc84fa2d, sha256 e82bf101b7e621b460d5d17da6355942a88b9fac4dc48b3178334ad24d267e49)
BibTeX
@misc{dcc0b5cc84fa2d,
title = {Efficacy and safety of a modified ozone-mediated neurolysis in treatment for patients with resistant hypertension — Europe PMC PMID:41238812},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41238812},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c0b5cc84fa2d; sha256 e82bf101b7e621b460d5d17da6355942a88b9fac4dc48b3178334ad24d267e49},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41238812. Agents can read the archived copy with the MCP tool read_document.